J&J Q2 Earnings Beat on Darzalex, Tremfya Growth, 2026 Outlook Raised
Johnson & Johnson’s JNJ second-quarter 2026 earnings came in at $2.90 per share, which beat the Zacks Consensus Estimate of $2.84.…
The Archive
Author: admin
See Which Recent 13F Filers Hold ABT But Andrew Hill Investment Advisors and Argent Capital Management Exited
At Holdings Channel, we have reviewed the latest batch of the 54 most recent 13F filings for the 06/30/2026 reporting…
Injective Joins x402 Foundation as AI Agent Economy Gains Momentum
The Injective ecosystem just added another milestone to its growing AI ambitions. The blockchain has officially become a core member…
Corn Starting Wednesday with Gains
Corn prices are up 3 to 4 cents so far on Wednesday morning with spillover support from double digit gains…
Why investors should consider selling AEHR stock on post-earnings rally
Aehr Test Systems (AEHR) is exploding higher on July 15 after posting blowout Q4 earnings and offering an absolute stunner…
5 Stocks to Buy If the Market Drops Again
In this video, I will cover the stocks I would be adding to my portfolio if the market pulls back…